BSEInsider Trading / SAST9 Sept 2026 · 9 Sept 2026, 07:57 pm

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Hemal Vasantrai Mehta

Sudarshan Pharma Industries Ltd · 543828

✦ AI SummaryPledge

Sudarshan Pharma Industries Ltd has submitted a revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the release of pledge of 20,00,000 equity shares held by Mr. Hemal Vasantrai Mehta, a promoter of the company.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sudarshan Pharma Industries Ltd - 543828 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Attachments (1)

📄

53DBCFF8_01DE_4651_BBD7_A8697E4C40D8_195739.pdf

pdf

Download →
View document text
XUDIRTHIII PHIRIIA IIIDU$IRIE$ tID Head Otfice : 301, Aura Biplex, Premium Retail Premi$e$, 7, S.V. Road, Borivali (West), Mumbai - 400092, E"mail : compliance@sudarshanpharma.com Websile; rruww.sudarshanpharma,com Board Line : +91'22-42221111 143331 111 I 42221116 (100 line) r $1p : 151496MH2008P1C184997 s P rLlcsl:-i E/2026-?027 lsB Date: 9th September, 2026 The Listing Department BSE Scrip Code: 543828 BSE Lin':ited BSE Trading Symbol: SUDARSHAN Phiroze Jeejeebhoy Torvers, lSlN: lNE00TV01023 Dalal Street, IVumbai - 400 001 Sub lntimation as per Regulation 31(1) & 31(2) of SEBI (Substantial Acquisition of Shares and Ta keovers) Regu lations, ?OLt As per i,our email dated 4il'september 2026, Please find enclosed the revised disclosure as per the Regulaticn 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in connectit)n with intirn.ation of release of pledge of 20,00,000 equity shares of the Company held by IVlr. Hemal IVlehta, Promoter of the Company. iiequest ),ou to take t he same on record i:or, Sudarshan Pharma lndustries Limited \1.>/L I \ U* t{irav Shah Compan',, Secretary & Complian i:nci: As ,,uove Regd. Otl. : S01, Aura Biplex, Above Kaly*n Jewellers, $.V. Road, Borivali (West), Mumbai - 400092. P+ *- oE r o)x -c i(D\ .-. so 9{$ -= (U!. ^6= - z C u+ lJ/1,- = . C; ) -Y :' oc --Y(/ i) 5(f) X iil * o(D q.) Otoh cloJ tE o\ -i o{i e :ij Y- r - .LXnr -\2. 1) ;-j n(U tr 0J :o -c(D _(E $ E:fr p3 ia ( r4 ^E'! E! ; .=Y s fro tr i6 L() .(zu_ E '-c (* rr )o N * o- o.rlt s m == c()sr ro Oc f @ -<l a: o v) () o o 't *< :f $ O C o "ct- oA co C) ) E d)re lL ) L c) o 1 :wl nr E Lu, c O)_ o l -- $4. _ C C (-_ ))r , .o iL a ) U(] Po roL S LgO O 5kXEcFE H 8rn C c: q) o) Co^= (E LG u O -r !f) f Fi-:c - (j . E(c 6 - cr) tU ( 0rU Jc f5 oC i JE o d BE I 6 oL E \." (E L ( - LU 0) o sE oE E_C E u5 ) , :t Es Cr bF0 O. C- e-. (- U H- rt Ea 5r O- - cC c(o r FZ f ( $l l f ) c) q+a o-c , -C0 ( : qfr l )) t - =o$ c- ( gFo oC 0 )-) FO * c E i =\ ( l- J= v-: Co 6 u . -) ) , - c -( c, a E! - -)r2 sn o) ' Iq o oo) ) :c E o E at Or -( gE5 ) :- {: Lu rt $ Tt -r $ L C Cq )) A:0o !l' Io* j Eo. g- r + pS -o0 O) ( N O ( ru; .- o-- i in C_ : #(o ) ( No ( (L !) "(-)-o -Lo = ( Oo ( :0 ;aI .') ) c 6g l l t l- (m a Lc o :E O N ooI) IE o oo r (E) -o _\L=b\'= sl€ 0) ao l l:" alt3 u a ml o OI) L -L Eo gHg$ to o q) Xm a - ..X ' q1 -a c7 Cu t " ^a J- )r -C L aC) l:q $ U) :c C C iJ h-o ;* o :- 9+$ (qU . vO: \ ). .-l sr o c @\ o -C {t) b ^L- i (Ef^ rt o ^ : (( -r )'A) : l:G L a1} .C c L) Y LoC o0J () so d 9 q(/) Oo o o F C c C o I! 1A () (o ,n a) Oq) :F N N fC- or )= .a Aln C r c' i-r , UO i (n u) o C) o E o $a6 )o .( o o Co L rc f )o()^: $og sE ;O= s N s o O N ( N . < 1E r co (.Lo E o9o o $c) () Prr I n(J - Zu (a $C )1l += z- A 0. ( f #( , z) C nr!) oo { L (o)- z*c o h'(- ocu 3r - o a + zr t6i s! : "e^4n o. -r- l2-i Oll oL ). -F= ( 5o Ee E Hs (o LE ctr );